Anti-G3ST1/ GAL3ST1/ CST functional antibody

Anti-G3ST1/ GAL3ST1/ CST functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GAL3ST1/GAL3ST1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0229-Ab-1/ GM-Tg-hg-SE0229-Ab-2Anti-Human GAL3ST1 monoclonal antibodyHuman
GM-Tg-rg-SE0229-Ab-1/ GM-Tg-rg-SE0229-Ab-2Anti-Rat GAL3ST1 monoclonal antibodyRat
GM-Tg-mg-SE0229-Ab-1/ GM-Tg-mg-SE0229-Ab-2Anti-Mouse GAL3ST1 monoclonal antibodyMouse
GM-Tg-cynog-SE0229-Ab-1/ GM-Tg-cynog-SE0229-Ab-2Anti-Cynomolgus/ Rhesus macaque GAL3ST1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0229-Ab-1/ GM-Tg-felg-SE0229-Ab-2Anti-Feline GAL3ST1 monoclonal antibodyFeline
GM-Tg-cang-SE0229-Ab-1/ GM-Tg-cang-SE0229-Ab-2Anti-Canine GAL3ST1 monoclonal antibodyCanine
GM-Tg-bovg-SE0229-Ab-1/ GM-Tg-bovg-SE0229-Ab-2Anti-Bovine GAL3ST1 monoclonal antibodyBovine
GM-Tg-equg-SE0229-Ab-1/ GM-Tg-equg-SE0229-Ab-2Anti-Equine GAL3ST1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0229-Ab-1/ GM-Tg-hg-SE0229-Ab-2; GM-Tg-rg-SE0229-Ab-1/ GM-Tg-rg-SE0229-Ab-2;
GM-Tg-mg-SE0229-Ab-1/ GM-Tg-mg-SE0229-Ab-2; GM-Tg-cynog-SE0229-Ab-1/ GM-Tg-cynog-SE0229-Ab-2;
GM-Tg-felg-SE0229-Ab-1/ GM-Tg-felg-SE0229-Ab-2; GM-Tg-cang-SE0229-Ab-1/ GM-Tg-cang-SE0229-Ab-2;
GM-Tg-bovg-SE0229-Ab-1/ GM-Tg-bovg-SE0229-Ab-2; GM-Tg-equg-SE0229-Ab-1/ GM-Tg-equg-SE0229-Ab-2
Products NameAnti-GAL3ST1 monoclonal antibody
Formatmab
Target NameGAL3ST1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GAL3ST1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0229-Ag-1Recombinant multi-species G3ST1/ GAL3ST1/ CST protein


    Target information

    Target IDGM-SE0229
    Target NameGAL3ST1
    Gene ID9514,53897,683713,715998,611960,101092797,513295,100063781
    Gene Symbol and SynonymsCST,GAL3ST1,Gcst
    Uniprot AccessionQ99999,A6QNK1
    Uniprot Entry NameG3ST1_HUMAN,G3ST1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000128242
    Target ClassificationN/A

    The target: GAL3ST1, gene name: GAL3ST1, also named as CST. Sulfonation, an important step in the metabolism of many drugs, xenobiotics, hormones, and neurotransmitters, is catalyzed by sulfotransferases. This gene encodes galactosylceramide sulfotransferase, which catalyzes the sulfation of membrane glycolipids including the final step in the synthesis of sulfatide, a major lipid component of the myelin sheath. This gene exhibits elevated expression in ovarian epithelial carcinoma and the encoded enzyme exhibits elevated activity in renal cell carcinoma. Mutations in this gene may be associated with reduced insulin resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.